2016-07-11 17:58:52 UTC

Gut Microbiota Developments with Emphasis on IBD

July 11, 2016

Report from the 2016 Gut Microbiota for Health World Summit is now available in Gastro.

In March 2016, leading microbiome experts from all over the world presented state-of-the-art gut microbiota science to an audience of scientists, clinicians, nutritionists, students, journalists, and representatives from the food and pharmaceutical industries at the 2016 Gut Microbiota for Health World Summit.

Hester Eppinga, along with several other attendees, have published a meeting summary in Gastroenterology highlighting the updates presented at this summit, including the pitfalls and future promises regarding the microbiome. This summary includes a special emphasis on IBD, in which the involvement of the microbiota is of high interest and is being widely studied.

Topics covered in the meeting summary include:

  • Diet: what has changed in the environment?
  • Life events that alter gut microbiota.
  • Gut microbiota dysbiosis in “IBD subsets.”
  • Gut microbiota interventions.
  • Gut microbiota as therapeutics.
  • Meeting conclusions and future implications for IBD patients.

The Gut Microbiota for Health World Summit is a collaborative effort between AGA and the European Society of Neurogastroenterology & Motility. Review the full meeting summary (login required).

More on Fecal microbiota transplant

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

AGA’s Fecal Microbiota Transplantation (FMT) National Registry Enrolls 1st Patient

Jan. 10, 2018

The registry, which promises to be the largest FMT study, also announces collaborations with American Gut and OpenBiome.

Largest Planned Fecal Microbiota Transplantation (FMT) Study Enrolls 1st Patient

Jan. 10, 2018

The AGA FMT National Registry also announces collaborations with American Gut and OpenBiome.